Hydroxyethyl Starch 130/0.42 versus Ringer's Acetate in Severe Sepsis
Rigshospitalet · Copenhagen University Hospital · +9 more institutions
Indexed incrossrefpubmed
Abstract
Background
Hydroxyethyl starch (HES) [corrected] is widely used for fluid resuscitation in intensive care units (ICUs), but its safety and efficacy have not been established in patients with severe sepsis.
Methods
In this multicenter, parallel-group, blinded trial, we randomly assigned patients with severe sepsis to fluid resuscitation in the ICU with either 6% HES 130/0.42 (Tetraspan) or Ringer's acetate at a dose of up to 33 ml per kilogram of ideal body weight per day. The primary outcome measure was either death or end-stage kidney failure (dependence on dialysis) at 90 days after randomization.
Citation impact
1,826
total citations
- FWCI
- 123.52
- Percentile
- 100%
- References
- 34
Citations per year
Authors
32Topics & keywords
Topics
Keywords
- Hydroxyethyl starch
- Sepsis
- Ringer's solution
- Starch
- Chemistry
- Anesthesia
- Medicine
- Biochemistry
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.